Viewing Study NCT05981703


Ignite Creation Date: 2025-12-24 @ 7:12 PM
Ignite Modification Date: 2026-02-23 @ 8:31 PM
Study NCT ID: NCT05981703
Status: RECRUITING
Last Update Posted: 2025-10-24
First Post: 2023-07-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
Sponsor: BeiGene
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumor View
None Solid Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None advanced solid tumor View
None BGB-26808 View
None BGB-A317 View
None Tislelizumab View
None PD1 View
None HPK1 View